Article Details

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Is Worth Evaluating At $51.36

Retrieved on: 2021-02-06 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Is Worth Evaluating At $51.36. View article details on hiswai:

Excerpt

The next largest institutional holding, with 3.77 Million shares, is of Vanguard Group, Inc. (The)'s that is approximately 6.63% of outstanding shares.

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up